1. Human Resources
  2. Food & Drug
  3. Education
  4. Grants
  5. Healthcare
  6. Energy
  7. Environmental Compliance
  8. Broadband
  9. Finance
Home » Food & Drug Regulation Library
Thompson’s Drug & Device Enforcement & Litigation: Impact on 2008 and Beyond New Edition
Thompson’s Drug & Device Enforcement & Litigation: Impact on 2008 and Beyond New Edition Authors:  Dennis A. Tosh, Esq

Thompson’s Drug & Device Enforcement & Litigation: Impact on 2008 and Beyond gives you in-depth analysis of the major legal, regulatory, enforcement and litigation events through early 2008 affecting the drug and medical device industries. This book will help attorneys and the industry:

  • Plan legal strategy in 2008 and beyond,
  • Avoid lawsuits,
  • Save money, and
  • Prevent costly mistakes

The book includes insights from leading attorneys; essential summaries of major cases and court decisions; practice tools; and a case index of nearly 275 cases.

The chapters are divided into six broad areas for easy reference – Product Liability; Enforcement and Compliance; Sales & Promotion Compliance; Medical Device Compliance; Food and Drug Administration Amendments Act of 2007; and Clinical Trials.

 
 
For discounts on multiple copy orders, contact service@thompson.com or call 800-677-3789.
Print
  • One-Volume Sourcebook
$249.00
Plus $19.95 Shipping and Handling
Order by Fax
About This Publication
This resource provides:
  • thorough reporting of important developments
  • commentary and analysis from prominent attorneys who offer valuable expertise and insight
  • practical tips that can give you a heads-up on likely future developments – as well as guidance on best practices that can help you face the challenges confronting FDA-regulated companies and their counsel
  • table of cases with nearly 275 case references and a table of practice tools

New for the 2008 Edition:

  • The $4.85 billion Vioxx settlement, and what it means for product manufacturers, consumers, and mass product liability settlements.
  • Important decisions from the U.S. Supreme Court and other federal and state courts on the federal preemption of state law liability claims brought against drug and device manufacturers.
  • Sweeping new legislation boosting the FDA’s enforcement powers and new requirements for drug manufacturing, clinical trials and device regulation.
  • The latest developments involving the regulation of direct-to-consumer advertising.
  • Expanded use of the federal False Claims Act and the growing role of state false claims acts in the face of alleged fraud and abuse involving FDA-regulated products.

Nothing can help drug and device company officials and their counsel deal with these challenging times more than a clear understanding of the latest legal and regulatory developments and their likely effect during the years to come. Thompson’s Drug & Device Enforcement & Litigation: Impact on 2008 and Beyond will help you gain that understanding and prepare you for future events that will profoundly affect the drug and medical device industries.

About Your Order

You can review this product for 30 days. If you cancel within 30 days of receipt, you will receive a full credit upon return of the product together with a request for cancellation.

Audio Conferences

Thursday, September 09 2010
Clinical Trial SOPs: Ensure Your Procedures are Compliant and Followed Correctly

Tuesday, September 14 2010
A Drug Recall Case Study: Lessons Learned from a Widespread Drug Recall at a Major Pharmaceutical Company

Tuesday, September 21 2010
False Claims Act Liability for Pharmaceutical and Medical Device Companies: How Will Recent Changes Affect You?

Tuesday, September 28 2010
How Health Care Reform and Other New Legislation Will Affect the Regulation of Advertising and Promotion

Thursday, September 30 2010
FDA's Changes to the 510(k) Process: Are You Prepared?

Tuesday, October 05 2010
Device Complaint Handling: Implications for CAPA, Reporting, Recalls and More


Free Email Alert